Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05973669 · ClinicalTrials.gov registry record · NA

MED-EL Remote Care Multi-Center Feasibility Study

A NA study of Hearing Loss, Sensorineural and Hearing Disorders, sponsored by Med-El Corporation.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
5
Study locations

NCT05973669: Recruiting NA study of Hearing Loss, Sensorineural and Hearing Disorders, sponsored by Med-El Corporation.

NCT05973669 is a NA study of Hearing Loss, Sensorineural and Hearing Disorders that is actively recruiting participants, run by Med-El Corporation. The registered enrollment target is 50 participants, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05973669, a NA study of Hearing Loss, Sensorineural and Hearing Disorders, is actively recruiting participants, sponsored by Med-El Corporation.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
5
Study locations

Study Summary

MED-EL Remote Care is a way for MED-EL cochlear implant users to check their hearing and cochlear implant device from any location, without the need for a scheduled, in-person appointment with their audiologist. This study will assess the effectiveness, efficiencies, and useability of MED-EL Remote Care.

Primary Outcome

Number and proportion of fully completed Remote Care visits.

Conditions Studied

Hearing Loss, Sensorineural Hearing Disorders Cochlear Implant Cochlear Implants Cochlear Implant Recipients

Interventions

  • DEVICE MED-EL Remote Care

Study Locations (5)

Ontario

  • London Health Sciences Centre - London
  • Sunnybrook Health Sciences Centre - Toronto

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Michigan

  • University of Michigan - Ann Arbor

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-05
Est. Completion 2026-05
Phase NA
Med-El Corporation

14 total trials

What NCT05973669 shows while recruiting

NCT05973669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower).

The record links to 5 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which MED-EL Remote Care is the first listed.

NCT05973669 lists 5 locations in 4 states (Ontario, Iowa, Michigan).

Frequently Asked Questions

What is clinical trial NCT05973669 about?

NCT05973669 is a clinical study titled "MED-EL Remote Care Multi-Center Feasibility Study". MED-EL Remote Care is a way for MED-EL cochlear implant users to check their hearing and cochlear implant device from any location, without the need for a scheduled, in-person appointment with their audiologist. This study will assess the effectiveness, efficiencies, and useability of MED-EL Remote ...

What is the current status of trial NCT05973669?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-05. Estimated completion is 2026-05.

What conditions does trial NCT05973669 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Hearing Disorders, Cochlear Implant, Cochlear Implants, Cochlear Implant Recipients.

What interventions are being tested in trial NCT05973669?

The interventions under investigation include: MED-EL Remote Care (DEVICE).

Who is sponsoring clinical trial NCT05973669?

This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05973669 being conducted?

This trial has 5 study locations across Iowa, Michigan, North Carolina, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05973669's enrollment target sits among peer trials

50 9th of 20 higher than 9 of 20 other Hearing Loss, Sensorineural trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05973669

Source: ClinicalTrials.gov NCT05973669, the US trial registry maintained by the National Library of Medicine. NCT05973669 (small enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.